Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection

European Journal of Immunology

Volumn 44, Issue 7, 2014, Pages 2013-2024

  Bandaru, Anuradha ^a   Devalraju, Kamakshi P ^a   Paidipally, Padmaja ^b   Dhiman, Rohan ^b,d   Venkatasubramanian, Sambasivan ^b   Barnes, Peter F ^b,c   Vankayalapati, Ramakrishna ^b   Valluri, Vijayalakshmi ^a  

^a LEPRA Society   (India)

^b UNIVERSITY OF TEXAS   (United States)

^c Baylor UT Houston Center for AIDS Research   (United States)

^d NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Cytokine; Human; IL 17; M. tuberculosis

Indexed keywords

CYTOKINE; HUMAN; IL-17; M. TUBERCULOSIS;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; PHOSPHORYLATION; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUBERCULOSIS;

EID: 84904382708     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343680     Document Type: Article

References (58)

1. Flynn, J. L. and Chan, J., Immunology of tuberculosis. Annu. Rev. Immunol. 2001. 19: 93-129.
2. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B. and Bloom, B. R., Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U.S.A. 1992. 89: 12013-12017.
3. Rojas, R. E., Balaji, K. N., Subramanian, A. and Boom, W. H., Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. Infect. Immun. 1999. 67: 6461-6472.
4. Orme, I. M. and Collins, F. M., Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J. Exp. Med. 1983. 158: 74-83.
5. + T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 2008. 180: 1962-1970.
6. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007. 8: 369-377.
7. Lockhart, E., Green, A. M. and Flynn, J. L., IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 2006. 177: 4662-4669.
8. O'Garra, A., Stockinger, B. and Veldhoen, M., Differentiation of human T(H)-17 cells does require TGF-beta! Nat. Immunol. 2008. 9: 588-590.
9. Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M. and Murphy, K. M., Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006. 24: 677-688.
10. Paidipally, P., Periasamy, S., Barnes, P. F., Dhiman, R., Indramohan, M., Griffith, D. E., Cosman, D. et al., NKG2D-dependent IL-17 production by human T cells in response to an intracellular pathogen. J. Immunol. 2009. 183: 1940-1945.
11. Li, Q., Li, J., Tian, J., Zhu, B., Zhang, Y., Yang, K., Ling, Y. et al., IL-17 and IFN-gamma production in peripheral blood following BCG vaccination and Mycobacterium tuberculosis infection in human. Eur. Rev. Med. Pharmacol. Sci. 2012. 16: 2029-2036.
12. Marin, N. D., Paris, S. C., Rojas, M. and Garcia, L. F., Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis. Clin. Vaccine Immunol. 2012. 19: 1667-1676.
13. Jurado, J. O., Pasquinelli, V., Alvarez, I. B., Pena, D., Rovetta, A. I., Tateosian, N. L., Romeo, H. E. et al., IL-17 and IFN-gamma expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J. Leukoc. Biol. 2012. 91: 991-1002.
14. + T cells in latently infected individuals and patients with active TB. Tuberculosis (Edinb.) 2013. 93: 155-166.
15. Yang, X. O., Panopoulos, A. D., Nurieva, R., Chang, S. H., Wang, D., Watowich, S. S. and Dong, C., STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007. 282: 9358-9363.
16. Zhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E. et al., IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007. 8: 967-974.
17. Barber, D. L., Mayer-Barber, K. D., Feng, C. G., Sharpe, A. H. and Sher, A., CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 2011. 186: 1598-1607.
18. Lazar-Molnar, E., Chen, B., Sweeney, K. A., Wang, E. J., Liu, W., Lin, J., Porcelli, S. A. et al., Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 2010. 107: 13402-13407.
19. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
20. Antonysamy, M. A., Fanslow, W. C., Fu, F., Li, W., Qian, S., Troutt, A. B. and Thomson, A. W., Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J. Immunol. 1999. 162: 577-584.
21. Hamada, S., Umemura, M., Shiono, T., Tanaka, K., Yahagi, A., Begum, M. D., Oshiro, K. et al., IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J. Immunol. 2008. 181: 3456-3463.
22. Matsuzaki, G. and Umemura, M., Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol. Immunol. 2007. 51: 1139-1147.
23. Peng, M. Y., Wang, Z. H., Yao, C. Y., Jiang, L. N., Jin, Q. L., Wang, J. and Li, B. Q., Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis. Cell Mol. Immunol. 2008. 5: 203-208.
24. Singh, A., Vajpayee, M., Ali, S. A., Mojumdar, K., Chauhan, N. K. and Singh, R., HIV-1 diseases progression associated with loss of Th17 cells in subtype 'C' infection. Cytokine 2012. 60: 55-63.
25. Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W. et al., Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 2009. 206: 299-311.
26. Cheng, S. C., van, d. V., Smeekens, S., Joosten, L. A., Van der Meer, J. W., Kullberg, B. J. and Netea, M. G., Candida albicans dampens host defense by downregulating IL-17 production. J. Immunol. 2010. 185: 2450-2457.
27. Yang, B., Wang, Y., Zhao, C., Yan, W., Che, H., Shen, C. and Zhao, M., Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection. Immunol. Lett. 2013. 149: 41-49.
28. Mbow, M., Larkin, B. M., Meurs, L., Wammes, L. J., de Jong, S. E., Labuda, L. A., Camara, M. et al., T-helper 17 cells are associated with pathology in human schistosomiasis. J. Infect. Dis. 2013. 207: 186-195.
29. Jain, A., Pandey, N., Garg, R. K. and Kumar, R., IL-17 Level in Patients with Dengue Virus Infection & its Association with Severity of Illness. J. Clin. Immunol. 2012. 33: 613-618.
30. Kurai, D., Nakagaki, K., Wada, H., Saraya, T., Kamiya, S., Fujioka, Y., Nakata, K. et al., Mycoplasma pneumoniae Extract Induces an IL-17-Associated Inflammatory Reaction in Murine Lung: Implication for Mycoplasmal Pneumonia. Inflammation 2012. 36: 285-293.
31. Mosolygo, T., Korcsik, J., Balogh, E. P., Faludi, I., Virok, D. P., Endresz, V. and Burian, K., Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation. Inflamm. Res. 2013. 62: 451-460.
32. Khader, S. A., Pearl, J. E., Sakamoto, K., Gilmartin, L., Bell, G. K., Jelley-Gibbs, D. M., Ghilardi, N. et al., IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 2005. 175: 788-795.
33. Wozniak, T. M., Ryan, A. A. and Britton, W. J., Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J. Immunol. 2006. 177: 8684-8692.
34. Yannam, G. R., Gutti, T. and Poluektova, L. Y., IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS. J. Neuroimmune. Pharmacol. 2012. 7: 95-112.
35. Gopal, R., Rangel-Moreno, J., Slight, S., Lin, Y., Nawar, H. F., Fallert Junecko, B. A., Reinhart, T. A. et al., Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol. 2013. 6: 972-984.
36. Umemura, M., Yahagi, A., Hamada, S., Begum, M. D., Watanabe, H., Kawakami, K., Suda, T. et al., IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 2007. 178: 3786-3796.
37. Okamoto, Y. Y., Umemura, M., Yahagi, A., O'Brien, R. L., Ikuta, K., Kishihara, K., Hara, H. et al., Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J. Immunol. 2010. 184: 4414-4422.
38. Cowan, J., Pandey, S., Filion, L. G., Angel, J. B., Kumar, A. and Cameron, D. W., Comparison of interferon-gamma-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. Clin. Exp. Immunol. 2012. 167: 317-329.
39. + T Cells. Am. J. Respir. Crit. Care Med. 2010. 181: 734-742.
40. Kumar, N. P., Anuradha, R., Suresh, R., Ganesh, R., Shankar, J., Kumaraswami, V., Nutman, T. B. et al., Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children. Clin. Vaccine Immunol. 2011. 18: 1856-1864.
41. McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., McClanahan, T. K. et al., The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 2009. 10: 314-324.
42. Xu, Y., Liu, Y., Pan, S., Liu, L., Liu, J., Zhai, X., Shen, H. et al., IL-23R polymorphisms, HBV infection, and risk of hepatocellular carcinoma in a high-risk Chinese population. J. Gastroenterol. 2013. 48: 125-131.
43. Riol-Blanco, L., Lazarevic, V., Awasthi, A., Mitsdoerffer, M., Wilson, B. S., Croxford, A., Waisman, A. et al., IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J. Immunol. 2010. 184: 1710-1720.
44. Khader, S. A. and Cooper, A. M., IL-23 and IL-17 in tuberculosis. Cytokine 2008. 41: 79-83.
45. Khader, S. A., Guglani, L., Rangel-Moreno, J., Gopal, R., Junecko, B. A., Fountain, J. J., Martino, C. et al., IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J. Immunol. 2011. 187: 5402-5407.
46. de Wit, J., Souwer, Y., van Beelen, A. J., de Groot, R., Muller, F. J., Klaasse, B. H., Jorritsma, T. et al., CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation. Blood 2011. 118: 6107-6114.
47. + memory T cells. J. Immunol. 2011. 186: 6182-6190.
48. Qin, H., Wang, L., Feng, T., Elson, C. O., Niyongere, S. A., Lee, S. J., Reynolds, S. L. et al., TGF-beta promotes Th17 cell development through inhibition of SOCS3. J. Immunol. 2009. 183: 97-105.
49. Romain, M., Taleb, S., Dalloz, M., Ponnuswamy, P., Esposito, B., Perez, N., Wang, Y. et al., Overexpression of SOCS3 in T Lymphocytes Leads to Impaired Interleukin-17 Production and Severe Aortic Aneurysm Formation in Mice-Brief Report. Arterioscler. Thromb. Vasc. Biol. 2013. 33: 581-584.
50. Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B. et al., Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 2009. 206: 2067-2077.
51. Kleinsteuber, K., Heesch, K., Schattling, S., Sander-Juelch, C., Mock, U., Riecken, K., Fehse, B. et al., SOCS3 promotes interleukin-17 expression of human T cells. Blood 2012. 120: 4374-4382.
52. Riley, J. L., PD-1 signaling in primary T cells. Immunol. Rev. 2009. 229: 114-125.
53. Sharpe, A. H., Wherry, E. J., Ahmed, R. and Freeman, G. J., The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007. 8: 239-245.
54. Rui, Y., Honjo, T. and Chikuma, S., Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response. Proc. Natl. Acad. Sci. U.S.A. 2013. 110: 16073-16078.
55. Hirahara, K., Ghoreschi, K., Yang, X. P., Takahashi, H., Laurence, A., Vahedi, G., Sciume, G. et al., Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 2012. 36: 1017-1030.
56. Garg, A., Barnes, P. F., Roy, S., Quiroga, M. F., Wu, S., Garcia, V. E., Krutzik, S. R. et al., Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur. J. Immunol. 2008. 38: 459-469.
57. Periasamy, S., Dhiman, R., Barnes, P. F., Paidipally, P., Tvinnereim, A., Bandaru, A., Valluri, V. L. et al., Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation With Mycobacterium tuberculosis. J. Infect. Dis. 2011. 203: 1256-1263.
58. Zhou, L., Lopes, J. E., Chong, M. M., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y. et al., TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008. 453: 236-240.